Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U1 small nuclear 131, pseudogene (RNU1-131P) is annotated as a pseudogene of the U1 small nuclear RNA (snRNA) family[9][1]. Pseudogenes are genomic DNA sequences similar to known genes but generally non-functional due to disruptions that prevent their normal expression or activity[3]. The U1 snRNA is a core component of the spliceosome, playing a critical role in pre-mRNA splicing[3][5], but RNU1-131P itself is not known to encode a functional RNA or protein, nor is it associated with any known disease role, therapeutic intervention, or molecular targeting. Unlike functional U1 snRNA genes, RNU1-131P is not considered a drug target and does not play a direct role in canonical biological pathways or disease mechanisms[9][1][3]. There is no evidence that this particular pseudogene is transcriptionally active, or exerts regulatory functions similar to some other recently described variant U1 snRNA pseudogenes[3]. Key context: - RNU1-131P is classified as a pseudogene, not a functional target or molecule for therapy[1][9]. - There is no indication of involvement in known biological functions or disease roles, and it is not targeted by drugs or used as a biomarker[1][9]. - Some U1 snRNA pseudogenes have been shown to be transcriptionally active and potentially exert regulatory functions[3][4], but there is no evidence that RNU1-131P itself is one of these cases[9][1]. Therefore, this entry is not a correct or useful molecular target for therapeutic or biomarker purposes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U1 small nuclear 131, pseudogene (RNU1-131P).